HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralph G Zinner Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

2/2014Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ralph G Zinner Research Topics

Disease

27Neoplasms (Cancer)
01/2021 - 01/2003
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018 - 07/2002
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2014
3Thrombocytopenia (Thrombopenia)
01/2019 - 02/2014
2Melanoma (Melanoma, Malignant)
01/2021 - 01/2019
2Fatigue
11/2016 - 08/2007
2Neutropenia
02/2014 - 04/2010
2Mesothelioma
07/2004 - 04/2004
2Prostatic Neoplasms (Prostate Cancer)
07/2003 - 01/2003
1Exanthema (Rash)
01/2021
1Adenocarcinoma of Lung
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Chronic Disease (Chronic Diseases)
11/2018
1Squamous Cell Carcinoma of Head and Neck
04/2016
1Histiocytic Sarcoma
01/2016
1Triple Negative Breast Neoplasms
12/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2013
1Neoplasm Metastasis (Metastasis)
01/2011
1Thromboembolism
01/2011
1Fever (Fevers)
04/2010
1Esophagitis
01/2009
1Lung Neoplasms (Lung Cancer)
08/2007
1Vomiting
08/2007
1Dehydration (Water Stress)
08/2007
1Nausea
08/2007
1Agranulocytosis (Granulocytopenia)
08/2007
1Diarrhea
03/2006
1Disease Progression
01/2003
1Breast Neoplasms (Breast Cancer)
07/2002

Drug/Important Bio-Agent (IBA)

9Pemetrexed (MTA)FDA Link
11/2018 - 04/2004
8Carboplatin (JM8)FDA LinkGeneric
01/2019 - 12/2005
4Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 09/2010
4Bevacizumab (Avastin)FDA Link
04/2016 - 02/2010
4Cisplatin (Platino)FDA LinkGeneric
08/2007 - 04/2004
3ParaffinIBA
01/2016 - 08/2014
3Formaldehyde (Formol)FDA Link
01/2016 - 08/2014
3GemcitabineFDA Link
04/2010 - 04/2004
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 01/2019
2VemurafenibIBA
01/2021 - 01/2019
2PlatinumIBA
11/2018 - 03/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 12/2014
2Cetuximab (Erbitux)FDA Link
04/2016 - 10/2013
2DNA (Deoxyribonucleic Acid)IBA
09/2015 - 05/2015
2Biomarkers (Surrogate Marker)IBA
08/2014 - 05/2007
2Drug CombinationsIBA
02/2014 - 03/2009
2Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013 - 06/2011
2Hemoglobins (Hemoglobin)IBA
01/2011 - 03/2006
2Docetaxel (Taxotere)FDA Link
04/2010 - 08/2007
2Canertinib (CI 1033)IBA
05/2007 - 05/2005
2AntimetabolitesIBA
07/2004 - 04/2004
2Trastuzumab (Herceptin)FDA Link
04/2004 - 07/2002
1Sorafenib (BAY 43-9006)FDA Link
01/2021
1CrizotinibIBA
01/2021
1CreatinineIBA
01/2019
1Sirolimus (Rapamycin)FDA Link
10/2016
1VorinostatFDA Link
10/2016
1Histone Deacetylase InhibitorsIBA
10/2016
1temsirolimusFDA Link
04/2016
1Cell-Free Nucleic AcidsIBA
01/2016
11- (3- C- ethynylribopentofuranosyl)cytosineIBA
02/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2014
1NucleotidesIBA
01/2014
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2010
1Filgrastim (Neupogen)FDA Link
04/2010
1Taxoids (Taxanes)IBA
04/2010
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2010
1Antineoplastic Agents (Antineoplastics)IBA
08/2007
1AntioxidantsIBA
08/2007
1motexafin gadoliniumIBA
08/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2007
1ErbB Receptors (EGF Receptor)IBA
05/2007
1Gefitinib (Iressa)FDA Link
03/2006
1Amifostine (Ethyol)FDA LinkGeneric
04/2004
1Liposomes (Liposome)IBA
07/2003
1AntibodiesIBA
01/2003
1Peptides (Polypeptides)IBA
01/2003
1Monoclonal AntibodiesIBA
07/2002

Therapy/Procedure

12Therapeutics
11/2018 - 05/2005
4Drug Therapy (Chemotherapy)
01/2017 - 04/2004
3Radiotherapy
01/2009 - 04/2004
2Combination Drug Therapy (Combination Chemotherapy)
12/2014 - 04/2010
1Maintenance Chemotherapy
11/2018
1Continuity of Patient Care
11/2018
1Salvage Therapy
04/2010
1Chemoradiotherapy
04/2004